Zum Hauptinhalt springen

Fachveröffentlichungen

03. August 2025 | Fachveröffentlichungen

The Effects of Stigma on Naloxone Attitudes and Policy Endorsement (2)

The Effects of Stigma on Naloxone Attitudes and Policy Endorsement Naloxone is a life-saving medication that reverses opioid overdoses by blocking the effects of opioids and reversing overdose symptoms such as respiratory depression. Studies show t…

03. August 2025 | Fachveröffentlichungen

Having naloxone when you need it: Factors associated with owning and carrying naloxone among people who use opioids.

Having naloxone when you need it: Factors associated with owning and carrying naloxone among people who use opioids. Latkin CA, Dayton L, Bonneau H, Davey-Rothwell MA, Gaddis A, Falade-Nwulia O. Int J Drug Policy. 2025 Jul 8;143:104914…

03. August 2025 | Fachveröffentlichungen

Having naloxone when you need it: Factors associated with owning and carrying naloxone among people who use opioids. (2)

Having naloxone when you need it: Factors associated with owning and carrying naloxone among people who use opioids. Latkin CA, Dayton L, Bonneau H, Davey-Rothwell MA, Gaddis A, Falade-Nwulia O. Int J Drug Policy. 2025 Jul 8;143:104914…

03. August 2025 | Fachveröffentlichungen

The implementation of take-home naloxone: Lessons learned from a 3-year take-home naloxone project in Germany.

The implementation of take-home naloxone: Lessons learned from a 3-year take-home naloxone project in Germany. Fleißner S, Steimle L, Schäffer D, Werse B, Deimel D, Kuban M, Stöver H. Harm Reduct J. 2025 Jul 18;22(1):120. doi: 10.1186/…

03. August 2025 | Fachveröffentlichungen

The implementation of take-home naloxone: Lessons learned from a 3-year take-home naloxone project in Germany. (2)

The implementation of take-home naloxone: Lessons learned from a 3-year take-home naloxone project in Germany. Fleißner S, Steimle L, Schäffer D, Werse B, Deimel D, Kuban M, Stöver H. Harm Reduct J. 2025 Jul 18;22(1):120. doi: 10.1186/…

03. August 2025 | Fachveröffentlichungen

Naloxone dosing: An evolving unregulated drug landscape, care setting considerations, and the need for research.

Naloxone dosing: An evolving unregulated drug landscape, care setting considerations, and the need for research. Wong, J.S.H., Lau, A. and Azar, P. (2025), Addiction. doi.org/10.1111/add.70144 https://onlinelibrary.wiley.com/doi/full/…

03. August 2025 | Fachveröffentlichungen

Naloxone dosing: An evolving unregulated drug landscape, care setting considerations, and the need for research. (2)

Naloxone dosing: An evolving unregulated drug landscape, care setting considerations, and the need for research. Wong, J.S.H., Lau, A. and Azar, P. (2025), Addiction. doi.org/10.1111/add.70144 https://onlinelibrary.wiley.com/doi/full/…

Weitere Beiträge ansehen

Weitere
akutelle Informationen
zu den Themengebieten